UBS AM
NUTX

UBS AM’s Nutex Health NUTX Stock Holding History

UBS AM’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$752K Buy
4,399
+1,980
+82% +$251K ﹤0.01% 2422
2026
Q1 		$230K Buy
2,419
+479
+25% +$58.7K ﹤0.01% 2707
2025
Q4 		$319K Buy
+1,940
New +$257K ﹤0.01% 2406
2025
Q3 		– Sell
-4,833
Closed -$602K – 2486
2025
Q2 		$602K Buy
+4,833
New +$624K ﹤0.01% 2467
2023
Q4 		– Sell
-2,173
Closed -$66K – 2583
2023
Q3 		$66K Hold
2,173
– – ﹤0.01% 2576
2023
Q2 		$329K Hold
2,173
– – ﹤0.01% 2448
2023
Q1 		$329K Hold
2,173
– – ﹤0.01% 2448
2022
Q4 		$619K Buy
+2,173
New +$417K ﹤0.01% 2088

Other funds holding NUTX

PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

UBS AM's NUTX Position: Q2 2026 in Review

UBS AM increased its Nutex Health (NUTX) stake by 82% in Q2 2026, buying an estimated $251K and bringing the position to 4,399 shares worth $752K. The position accounts for ﹤0.01% of the portfolio, ranked #2422.

UBS AM first reported a position in NUTX in Q4 2022 and has held it in 8 quarters since. 154 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • UBS AM held 4,399 shares of Nutex Health worth $752K as of Q2 2026.
  • UBS AM bought 1,980 Nutex Health shares in Q2 2026, an estimated $251K.
  • Nutex Health made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2422 holding.
  • UBS AM first reported a position in Nutex Health in Q4 2022 and has held it in 8 quarters since.
  • 154 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.